Multifocal motor neuropathy

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
ATC code not specified 2
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 1 Phase II: 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial

Phase II

2 trials
  • Argenx Commercial
    EMPASIPRUBART
    2023-507052-69-00 8 countries 2023 n=34
    Ended
  • Dianthus Therapeutics Inc. Commercial
    DNTH103
    2024-513128-40-00 6 countries 2025 n=11
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Argenx Commercial 2 Phase II, Phase III 0
Dianthus Therapeutics Inc. Commercial 1 Phase II 1
New trials by year
2023
1
2025
2
← All indication landscapes